A cannabinoid receptor 1 polymorphism is protective against major depressive disorder in methadone‐maintained outpatients

Abstract

Despite limitations due to the modest sample size, our results are consistent with previous research on the endocannabinoid system and suggest new leads for detecting subjects at risk of MDD, which remains insufficiently diagnosed and treated in patients suffering from severe addictive disorders.